Vanguard Group
KYMR icon

Vanguard Group’s Kymera Therapeutics KYMR Stock Holding History

Vanguard Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$488M Buy
6,267,644
+845,922
+16% +$57.1M 0.01% 1076
2025
Q3 		$307M Sell
5,421,722
-198,126
-4% -$8.94M ﹤0.01% 1317
2025
Q2 		$245M Buy
5,619,848
+388,456
+7% +$13.4M ﹤0.01% 1413
2025
Q1 		$143M Buy
5,231,392
+344,080
+7% +$12.5M ﹤0.01% 1633
2024
Q4 		$197M Buy
4,887,312
+133,546
+3% +$6.03M ﹤0.01% 1548
2024
Q3 		$225M Sell
4,753,766
-68,650
-1% -$3.03M ﹤0.01% 1485
2024
Q2 		$144M Buy
4,822,416
+55,366
+1% +$1.92M ﹤0.01% 1667
2024
Q1 		$192M Buy
4,767,050
+769,486
+19% +$27.5M ﹤0.01% 1548
2023
Q4 		$102M Buy
3,997,564
+72,351
+2% +$1.29M ﹤0.01% 1857
2023
Q3 		$54.6M Buy
3,925,213
+182,125
+5% +$3.66M ﹤0.01% 2088
2023
Q2 		$86.1M Buy
3,743,088
+9,163
+0.2% +$263K ﹤0.01% 1933
2023
Q1 		$111M Buy
3,733,925
+73,618
+2% +$2.37M ﹤0.01% 1783
2022
Q4 		$91.4M Buy
3,660,307
+797,130
+28% +$21.3M ﹤0.01% 1848
2022
Q3 		$62.3M Sell
2,863,177
-11,547
-0.4% -$304K ﹤0.01% 2075
2022
Q2 		$56.6M Buy
2,874,724
+36,999
+1% +$864K ﹤0.01% 2140
2022
Q1 		$120M Sell
2,837,725
-119,449
-4% -$5.04M ﹤0.01% 1840
2021
Q4 		$188M Buy
2,957,174
+55,600
+2% +$3.24M ﹤0.01% 1650
2021
Q3 		$170M Buy
2,901,574
+857,350
+42% +$49.7M ﹤0.01% 1697
2021
Q2 		$99.1M Buy
2,044,224
+311,879
+18% +$13.5M ﹤0.01% 2007
2021
Q1 		$67.3M Buy
1,732,345
+1,109,285
+178% +$66.8M ﹤0.01% 2147
2020
Q4 		$38.6M Buy
623,060
+157,010
+34% +$7.66M ﹤0.01% 2331
2020
Q3 		$15.1M Buy
+466,050
New +$14.2M ﹤0.01% 2587

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return